EHRA Premium Access

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks: drugs?

Congress Presentation

About the speaker

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)
32 presentations
0 follower

5 more presentations in this session

What will improve the results of VT ablation? Better mapping.

Speaker: Doctor P. Maury (Toulouse, FR)

Thumbnail

What will improve the results of VT ablation? Better technology.

Speaker: Professor J. Kautzner (Prague, CZ)

Thumbnail

What will improve the results of VT ablation? - rebuttal and discussion.

Thumbnail

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks: ablation?

Speaker: Doctor M. Saba (London, GB)

Thumbnail

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks - rebuttal and discussion.

Thumbnail

Access the full session

Controversies in ventricular tachycardia (VT) ablation

Speakers: Professor A. Goette, Doctor P. Maury, Professor J. Kautzner, Doctor M. Saba
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk